Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; 20210101, Issue: Preprints
- Subject
- Language
- ISSN
- 22132600; 22132619